Specific accumulation of 18F-deoxyglucose in three-dimensional long-term cultures of human and rodent brain tissue

NuklearMedizin

Volumn 46, Issue 6, 2007, Pages 233-238

  Hocke, Carsten ^a,b   Blumcke I ^a   Romstock J ^a   Prante, O ^a   Stefan, H ^a   Kuwert, T ^a   Jeske, I ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Clinic of Nuclear Medicine   (Germany)

Author keywords

18F deoxyglucose; Autoradiography; Glucose metabolism; Organotypic brain cultures; Radioimaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; PHOSPHATE BUFFERED SALINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN SLICE; BRAIN TISSUE; EPILEPSY; EX VIVO STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NONHUMAN; POSTNATAL DEVELOPMENT; QUANTITATIVE ANALYSIS; RADIOACTIVITY; RAT; RODENT; STATISTICAL SIGNIFICANCE; TISSUE CULTURE; WISTAR RAT; ANIMAL; CYTOLOGY; KINETICS; MOUSE; ORGAN CULTURE TECHNIQUE; SCINTISCANNING;

ANIMALS; AUTORADIOGRAPHY; FLUORODEOXYGLUCOSE F18; HIPPOCAMPUS; HUMANS; KINETICS; MICE; ORGAN CULTURE TECHNIQUES; RADIOPHARMACEUTICALS; RATS;

EID: 37349131208     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0100     Document Type: Article

References (32)

1. Biersack HJ, Bender H, Ruhlmann J et al. Clinical PET in oncology. Rev Esp Med Nucl 2000; 19: 219-224.
2. 131I-Iodide. J Nucl Med 2006; 47: 1382-1388.
3. Blümcke I, Wiestier OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol. 2002; 61: 575-584.
4. Brichta L, Hofmann Y, Hahnen E et al. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 2003; 12: 2481-2489.
5. Charon Y, Laniece P, Tricoire H. Radio-Imaging for quantitative autoradiography in biology. Nucl Med Biol 1998; 25: 699-704.
6. Dorr J, Roth K, Zurbuchen U et al. Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)-mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate. J Neuroimmunol. 2005; 167: 204-209.
7. Eichenbaum H, Harris K. Toying with memory in the hippocampus. Nat Neurosci 2000; 3: 205-206.
8. Elger CE. Epilepsy: disease and model to study human brain function. Brain Pathol 2002; 12: 193-198.
9. Eriksson PS, Perfilieva E, Bjork-Eriksson T et al. Neurogenesis in the adult human hippocampus. Nat Med 1998; 4: 1313-1317.
10. Eyupoglu I Y, Savaskan N E, Brauer A U et al. Identification of neuronal cell death in a model of degeneration in the hippocampus. Brain Res Brain Res Protoc 2003; 11: 1-8.
11. Eyupoglu I, Hahnen E, Tränkle C et al. Experimental therapy of malignant gliomas using the inhibitor of histone deacetylases MS-275. Mol Cancer Ther 2006; 5: 1248-1255.
12. Eyupoglu IY, Hahnen E, Heckel A et al. Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. J Neurosurg 2005; 102: 738-744.
13. Grunwald F, Schrock H, Biersack HJ et al. Changes in local cerebral glucose utilization in the awake rat during acute and chronic administration of ethanol. J Nucl Med 1993; 34: 793-798.
14. Hahnen E, Eyupoglu IY, Brichta L et al. In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J Neurochem 2006; 98: 193-202.
15. Herholz K, Heiss WD. Positron Emission Tomography in clinical neurology. Mol Imaging Biol 2004; 6: 239-269.
16. Holsken A, Eyupoglu IY, Lueders M et al. Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases. Acta Neuropathol (Berl) 2006; 112: 205-215.
17. Kuwert T, Bartenstein P, Grünwald F et al. Klinische Wertigkeit der Positronenemissionstomographie in der Neuromedizin: Positionspapier zu den Ergebnissen einer interdisziplinären Konsensus-Konferenz. Nervenarzt 1998; 69: 1045-1060.
18. Laniece P, Charon Y, Cardona A et al. A new high resolution radioimager for the quantitative analysis of radiolabelled molecules in tissue section. J Neurosci Methods 1998; 86: 1.
19. 18F-2-fluoro-2-deoxyglucose signal in PET activation studies Mol Psychiatry 1996; 1: 445-452.
20. McEwen BS, Reagan LP. Glucose transporter expression in the central nervous system: relationship to synaptic function Eur J Pharmacol. 2004; 490: 13-24.
21. McKinney RA, Debanne D, Gähwiler BH et al. Lesion-induced axonal sprouting and hyperexcitability in the hippocampus in vitro: implications for the genesis of posttraumatic epilepsy. Nat Med 1997; 3: 990-996.
22. Nishii W, Shoda T, Matsumoto N et al. In situ visualization of caspase-1-like activity associated with promotion of hippocampal cell death. FEBS Lett 2002; 518: 149-153.
23. Ogawa M, Watabe H, Teramoto N et al. Understanding of cerebral energy metabolism by dynamic living brain slice imaging system with [18F]FDG. Neurosci Res 2005; 52: 357-361.
24. Ohnishi T, Matsumura H, Izumoto S et al. A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Res 1998; 58: 2935-2940.
25. Pauli E, Hildebrandt M, Romstock J et al. Deficient memory acquisition in temporal lobe epilepsy is predicted by hippocampal granule cell loss. Neurology 2006; 67: 1383-1389.
26. Prante O, Hocke C, Loeber S et al. Tissue distribution of radioiodinated FAUC113: assessment of a pyrazolo(1,5-a) pyridine based dopamine D4 receptor radioligand candidate Nuklearmedizin 2006; 45: 41-48.
27. 18F-2-fluoro-2-deoxy-D-glucose under oxygen deprivation in living brain slices using bioradiography. Synapse 2005; 55: 252-261.
28. Schmidt-Hieber C, Jonas P, Bischofberger J. Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature 2004; 429: 184-187.
29. Stoppini L, Buchs PA, Muller D A. Simple method for organotypic cultures of nervous tissue. J Neurosci Meth 1991; 37: 173-182.
30. van Praag H, Schinder AF, Christie BR et al. Functional neurogenesis in the adult hippocampus. Nature 2002; 415: 1030-1034.
31. Vinton AB, Carne R, Hicks RJ et al. The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain 2007; 130: 548-560.
32. 18F-2-fluoro-2-deoxy-D-glucose in brain slices of the rat. Neurosci Res 1998; 30: 271-278.